Latest Biologic Stories
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced a full agenda
A Different Mechanism of Action from the Currently Available Products is Entyvio's Most Commonly Cited Advantage, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept.
South Korea emerges among the frontrunners in the race to lead the global biosimilars market PHILADEPHIA, Sept.
REDWOOD CITY, Calif., Sept.
An Alliance Of 5 Companies Experienced In Biosimilars Development MANNHEIN, Germany, Sept.
SAN DIEGO, Sept. 19, 2014 /PRNewswire/ -- Pfenex Inc.
HRT will be showcasing its surgical amniotic product line of AmnioPro-C Flowable, AmnioPro – A Flowable, AmnioPro45™ Membrane, AmnioPro200™ Membrane and its In-Office amniotic product line
Arthritis Society says patient safety paramount as new class of medications become available Toronto, ON (PRWEB) September 18, 2014 With the arrival
Improved Efficacy and Lower List Price than the Anti-TNFs Will Be the Key Drivers for Prescribing of Emerging Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass.,
- The word or words serving to define another word or expression, as in a dictionary entry.